was read the article
array:22 [ "pii" => "S0001731012700029" "issn" => "00017310" "doi" => "10.1016/S0001-7310(12)70002-9" "estado" => "S300" "fechaPublicacion" => "2012-10-01" "aid" => "70002" "copyright" => "Academia Española de Dermatología y Venereología" "copyrightAnyo" => "2012" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:1-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1784 "formatos" => array:2 [ "HTML" => 1012 "PDF" => 772 ] ] "itemSiguiente" => array:18 [ "pii" => "S0001731012700030" "issn" => "00017310" "doi" => "10.1016/S0001-7310(12)70003-0" "estado" => "S300" "fechaPublicacion" => "2012-10-01" "aid" => "70003" "copyright" => "Academia Española de Dermatología y Venereología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:7-15" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2317 "formatos" => array:2 [ "HTML" => 1150 "PDF" => 1167 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Mecanismo de acción de ustekinumab y su relevancia en la patogénesis de la psoriasis. Impacto en el sistema inmune" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "7" "paginaFinal" => "15" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Mechanism of Action of Ustekinumab and its Relevance in the Pathogenesisof Psoriasis. Impact on the Immune System" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Carrascosa" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Carrascosa" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700030?idApp=UINPBA000044" "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700030/v1_201304241722/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Ustekinumab. Introducción. Estructura química. Farmacocinética e inmunogenicidad" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "6" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "E. Daudén" "autores" => array:1 [ 0 => array:3 [ "nombre" => "E." "apellidos" => "Daudén" "email" => array:1 [ 0 => "estebandauden@medynet.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Dermatología. Hospital Universitario de la Princesa. Madrid. España" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Ustekinumab. Introduction. Chemical Structure. Pharmacokinetics and immunogenicity" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec85078" "palabras" => array:7 [ 0 => "Ustekinumab" 1 => "Interleucina 12" 2 => "Interleucina 23" 3 => "Terapia biológica" 4 => "Psoriasis" 5 => "Enfermedad de Crohn" 6 => "Farmacocinética" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec85079" "palabras" => array:7 [ 0 => "Ustekinumab" 1 => "Interleukin 12" 2 => "Interleukin 23" 3 => "Biologic therapy" 4 => "Psoriasis" 5 => "Crohn disease" 6 => "Pharmacokinetics" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Se presenta el contenido de esta monografía sobre el conocimiento actual del ustekinumab, especialmente en relación con la psoriasis pero también en otras indicaciones. Se describe su estructura química, el proceso de obtención, se analizan los datos farmacocinéticos (absorción, distribución, metabolismo, eliminación), sus interacciones y se revisa la información relativa a la inmunogenicidad de la molécula.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">This chapter opens with a brief introduction to the content of this supplement summarizing our current knowledge of ustekinumab with a particular focus on psoriasis but also including other indications. In addition to describing the chemical structure and the process used to produce this biologic agent, the chapter analyzes the drug's pharmacokinetic profile (absorption, distribution, metabolism, and excretion) and interactions with other drugs. A review of the information relating to the immunogenicity of the molecule is also included.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:24 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.O. Nestle" 1 => "D.H. Kaplan" 2 => "J. Barker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra0804595" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "361" "paginaInicial" => "496" "paginaFinal" => "509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19641206" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "National Psoriasis Foundation National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.B. Kimball" 1 => "D. Gladman" 2 => "J.M. Gelfand" 3 => "K. Gordon" 4 => "E.J. Horn" 5 => "N.J. Korman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2008.01.006" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2008" "volumen" => "58" "paginaInicial" => "1031" "paginaFinal" => "1042" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18313171" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.S. Stern" 1 => "T. Nijsten" 2 => "S.R. Feldman" 3 => "D.J. Margolis" 4 => "T. Rolstad" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1087-0024.2003.09102.x" "Revista" => array:6 [ "tituloSerie" => "J Investig Dermatol Symp Proc" "fecha" => "2004" "volumen" => "9" "paginaInicial" => "136" "paginaFinal" => "139" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15083780" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ustekinumab SPC. (Acceso en Ago 2011). Disponible en: <a class="elsevierStyleInterRef" href="http://www.emea.europe.eu/humandocs/PDFs/EPAR/stelara/H-958-PI-en.pdf">http://www.emea.europe.eu/humandocs/PDFs/EPAR/stelara/H-958-PI-en.pdf</a>)." ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Ustekinumab Crohn's Disease Study Group" "etal" => true "autores" => array:6 [ 0 => "W.J. Sandborn" 1 => "B.G. Feagan" 2 => "R.N. Fedorak" 3 => "E. Scherl" 4 => "M.R. Fleisher" 5 => "S. Katz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.gastro.2008.07.014" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "2008" "volumen" => "135" "paginaInicial" => "1130" "paginaFinal" => "1141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18706417" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ustekinumab, a human interleukin-12/23 monoclonal antibody, for psoriatic arthritis: randomized, double-blind, placebo-controlled, crossover trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Gottlieb" 1 => "A. Menter" 2 => "A. Mendelsohn" 3 => "Y.K. Shen" 4 => "S. Li" 5 => "C. Guzzo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(09)60140-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2009" "volumen" => "373" "paginaInicial" => "633" "paginaFinal" => "640" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19217154" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Multiple Sclerosis Investigators" "etal" => true "autores" => array:6 [ 0 => "L.H. Kasper" 1 => "D. Everitt" 2 => "T.P. Leist" 3 => "K.A. Ryan" 4 => "M.A. Mascelli" 5 => "K. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1185/030079906X120931" "Revista" => array:6 [ "tituloSerie" => "Curr Med Res Opin" "fecha" => "2006" "volumen" => "22" "paginaInicial" => "1671" "paginaFinal" => "1678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16968570" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomized, dose-ranging study" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Ustekinumab MS Investigators" "etal" => false "autores" => array:6 [ 0 => "B.M. Segal" 1 => "C.S. Constantinescu" 2 => "A. Raychaudhuri" 3 => "L. Kim" 4 => "R. Fidelus-Gort" 5 => "L.H. Kasper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(08)70173-X" "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2008" "volumen" => "7" "paginaInicial" => "796" "paginaFinal" => "804" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18703004" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.M. Fishwild" 1 => "S.L. O’Donnell" 2 => "T. Bengoechea" 3 => "D.V. Hudson" 4 => "F. Harding" 5 => "S.L. Bernhard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nbt0796-845" "Revista" => array:6 [ "tituloSerie" => "Nat Biotechnol" "fecha" => "1996" "volumen" => "14" "paginaInicial" => "845" "paginaFinal" => "851" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9631008" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Yeilding" 1 => "P. Szapary" 2 => "C. Brodmerkel" 3 => "J. Benson" 4 => "M. Plotnick" 5 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1749-6632.2011.05963.x" "Revista" => array:6 [ "tituloSerie" => "Ann N Y Acad Sci" "fecha" => "2011" "volumen" => "1222" "paginaInicial" => "30" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21434940" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Benson" 1 => "C.W. Sachs" 2 => "G. Treacy" 3 => "H. Zhou" 4 => "C.E. Pendley" 5 => "C.M. Brodmerkel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nbt.1903" "Revista" => array:6 [ "tituloSerie" => "Nat Biotechnol" "fecha" => "2011" "volumen" => "29" "paginaInicial" => "615" "paginaFinal" => "624" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21747388" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Zhu" 1 => "C. Hu" 2 => "M. Lu" 3 => "S. Liao" 4 => "J.C. Marini" 5 => "J. Yohrling" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0091270008329556" "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2009" "volumen" => "49" "paginaInicial" => "162" "paginaFinal" => "175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19179295" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y.W. Zhu" 1 => "A. Mendelsohn" 2 => "C. Pendley" 3 => "H.M. Davis" 4 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Clin Pharmacol Ther" "fecha" => "2010" "volumen" => "48" "paginaInicial" => "830" "paginaFinal" => "846" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21084039" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ustekinumab for the treatment of plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "K. Reich" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Rev Dermatol" "fecha" => "2009" "volumen" => "4" "paginaInicial" => "443" "paginaFinal" => "453" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.B. Gottlieb" 1 => "K.D. Cooper" 2 => "T.S. McCormick" 3 => "E. Toichi" 4 => "D.E. Everitt" 5 => "B. Frederick" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1185/030079907X182112" "Revista" => array:6 [ "tituloSerie" => "Curr Med Res Opin" "fecha" => "2007" "volumen" => "23" "paginaInicial" => "1081" "paginaFinal" => "1092" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17519075" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transcytosis and catabolism of antibody" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V. Ghetie" 1 => "E.S. Ward" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1385/IR:25:2:097" "Revista" => array:6 [ "tituloSerie" => "Immunol Res" "fecha" => "2002" "volumen" => "25" "paginaInicial" => "97" "paginaFinal" => "113" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11999172" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Lebwohl" 1 => "N. Yeilding" 2 => "P. Szapary" 3 => "Y. Wang" 4 => "S. Li" 5 => "Y. Zhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2009.11.012" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2010" "volumen" => "63" "paginaInicial" => "571" "paginaFinal" => "579" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20599293" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0091270006294278" "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2006" "volumen" => "46" "paginaInicial" => "1268" "paginaFinal" => "1289" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17050792" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk-based strategy for the assessment of pharmacokinetic drug-drug interactions for therapeutic monoclonal antibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Zhou" 1 => "H.M. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.drudis.2009.05.014" "Revista" => array:6 [ "tituloSerie" => "Drug Discov Today" "fecha" => "2009" "volumen" => "14" "paginaInicial" => "891" "paginaFinal" => "898" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19520183" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "PHOENIX 1 study investigators" "etal" => true "autores" => array:6 [ 0 => "C.L. Leonardi" 1 => "A.B. Kimball" 2 => "K.A. Papp" 3 => "N. Yeilding" 4 => "C. Guzzo" 5 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60725-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2008" "volumen" => "371" "paginaInicial" => "1665" "paginaFinal" => "1674" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486739" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "PHOENIX 2 study investigators" "etal" => true "autores" => array:6 [ 0 => "K.A. Papp" 1 => "R.G. Langley" 2 => "M. Lebwohl" 3 => "G.G. Krueger" 4 => "P. Szapary" 5 => "N. Yeilding" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60726-6" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2008" "volumen" => "371" "paginaInicial" => "1675" "paginaFinal" => "1684" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486740" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "ACCEPT Study Group" "etal" => true "autores" => array:6 [ 0 => "C.E. Griffiths" 1 => "B.E. Strober" 2 => "P. Van de Kerkhof" 3 => "V. Ho" 4 => "R. Fidelus-Gort" 5 => "N. Yeilding" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0810652" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2010" "volumen" => "362" "paginaInicial" => "118" "paginaFinal" => "128" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20071701" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.L. Kauffman" 1 => "N. Aria" 2 => "E. Toichi" 3 => "T.S. McCormick" 4 => "K.D. Cooper" 5 => "A.B. Gottlieb" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.0022-202X.2004.23448.x" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2004" "volumen" => "123" "paginaInicial" => "1037" "paginaFinal" => "1044" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15610511" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "CNTO 1275 Psoriasis Study Group" "etal" => true "autores" => array:6 [ 0 => "G.G. Krueger" 1 => "R.G. Langley" 2 => "C. Leonardi" 3 => "N. Yeilding" 4 => "C. Guzzo" 5 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa062382" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "356" "paginaInicial" => "580" "paginaFinal" => "592" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17287478" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700029/v1_201304241722/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00017310/00000103000000S2/v1_201304241722/S0001731012700029/v1_201304241722/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700029?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 8 | 10 |
2024 October | 37 | 41 | 78 |
2024 September | 36 | 31 | 67 |
2024 August | 61 | 54 | 115 |
2024 July | 38 | 31 | 69 |
2024 June | 46 | 31 | 77 |
2024 May | 37 | 32 | 69 |
2024 April | 40 | 25 | 65 |
2024 March | 41 | 35 | 76 |
2024 February | 23 | 39 | 62 |
2024 January | 40 | 46 | 86 |
2023 December | 40 | 46 | 86 |
2023 November | 37 | 19 | 56 |
2023 October | 31 | 17 | 48 |
2023 September | 35 | 18 | 53 |
2023 August | 31 | 21 | 52 |
2023 July | 24 | 32 | 56 |
2023 June | 35 | 25 | 60 |
2023 May | 23 | 17 | 40 |
2023 April | 32 | 19 | 51 |
2023 March | 29 | 28 | 57 |
2023 February | 27 | 8 | 35 |
2023 January | 25 | 23 | 48 |
2022 December | 28 | 26 | 54 |
2022 November | 19 | 33 | 52 |
2022 October | 27 | 17 | 44 |
2022 September | 22 | 29 | 51 |
2022 August | 21 | 38 | 59 |
2022 July | 17 | 37 | 54 |
2022 June | 26 | 20 | 46 |
2022 May | 28 | 34 | 62 |
2022 April | 37 | 39 | 76 |
2022 March | 28 | 48 | 76 |
2022 February | 28 | 19 | 47 |
2022 January | 30 | 46 | 76 |
2021 December | 28 | 35 | 63 |
2021 November | 48 | 49 | 97 |
2021 October | 37 | 48 | 85 |
2021 September | 34 | 37 | 71 |
2021 August | 31 | 43 | 74 |
2021 July | 17 | 38 | 55 |
2021 June | 41 | 42 | 83 |
2021 May | 31 | 36 | 67 |
2021 April | 62 | 49 | 111 |
2021 March | 68 | 45 | 113 |
2021 February | 37 | 26 | 63 |
2021 January | 26 | 18 | 44 |
2020 December | 33 | 17 | 50 |
2020 November | 22 | 14 | 36 |
2020 October | 30 | 21 | 51 |
2020 September | 16 | 13 | 29 |
2020 August | 22 | 23 | 45 |
2020 July | 16 | 20 | 36 |
2020 June | 27 | 17 | 44 |
2020 May | 37 | 40 | 77 |
2020 April | 23 | 19 | 42 |
2020 March | 27 | 21 | 48 |
2020 February | 3 | 5 | 8 |
2019 December | 0 | 2 | 2 |
2019 October | 0 | 1 | 1 |
2019 September | 0 | 1 | 1 |
2019 August | 0 | 5 | 5 |
2019 July | 0 | 11 | 11 |
2019 June | 0 | 21 | 21 |
2019 May | 0 | 72 | 72 |
2019 April | 0 | 28 | 28 |
2019 March | 0 | 14 | 14 |
2019 February | 0 | 7 | 7 |
2019 January | 0 | 5 | 5 |
2018 December | 0 | 6 | 6 |
2018 November | 0 | 2 | 2 |
2018 October | 0 | 4 | 4 |
2018 September | 0 | 1 | 1 |
2018 August | 0 | 2 | 2 |
2018 July | 0 | 7 | 7 |
2018 June | 0 | 1 | 1 |
2018 May | 0 | 9 | 9 |
2018 March | 1 | 3 | 4 |
2018 February | 22 | 5 | 27 |
2018 January | 16 | 4 | 20 |
2017 December | 31 | 9 | 40 |
2017 November | 35 | 11 | 46 |
2017 October | 17 | 4 | 21 |
2017 September | 20 | 15 | 35 |
2017 August | 17 | 7 | 24 |
2017 July | 12 | 3 | 15 |
2017 June | 28 | 5 | 33 |
2017 May | 28 | 11 | 39 |
2017 April | 32 | 13 | 45 |
2017 March | 38 | 23 | 61 |
2017 February | 34 | 10 | 44 |
2017 January | 49 | 15 | 64 |
2016 December | 60 | 11 | 71 |
2016 November | 25 | 9 | 34 |
2016 October | 24 | 14 | 38 |
2016 September | 33 | 24 | 57 |
2016 August | 45 | 16 | 61 |
2016 July | 40 | 25 | 65 |
2016 June | 0 | 27 | 27 |
2016 May | 0 | 18 | 18 |
2016 April | 0 | 2 | 2 |
2016 March | 3 | 1 | 4 |
2016 February | 2 | 0 | 2 |
2016 January | 0 | 48 | 48 |
2015 December | 1 | 18 | 19 |
2015 November | 5 | 17 | 22 |
2015 October | 2 | 0 | 2 |
2015 September | 7 | 10 | 17 |
2015 August | 9 | 8 | 17 |
2015 July | 38 | 2 | 40 |
2015 June | 40 | 9 | 49 |
2015 May | 44 | 16 | 60 |
2015 April | 51 | 22 | 73 |
2015 March | 27 | 12 | 39 |
2015 February | 37 | 16 | 53 |
2015 January | 26 | 20 | 46 |
2014 December | 38 | 20 | 58 |
2014 November | 34 | 18 | 52 |
2014 October | 32 | 38 | 70 |
2014 September | 0 | 1 | 1 |
2014 August | 2 | 0 | 2 |
2014 July | 0 | 1 | 1 |
2014 May | 1 | 0 | 1 |
2014 January | 1 | 1 | 2 |
2013 November | 0 | 1 | 1 |
2013 September | 0 | 1 | 1 |
2013 July | 0 | 1 | 1 |
2013 June | 3 | 3 | 6 |
2013 May | 1 | 2 | 3 |
2013 April | 1 | 1 | 2 |
2013 February | 0 | 1 | 1 |
2013 January | 0 | 1 | 1 |